Fermata Advisors, LLC Charles River Laboratories International, Inc. Transaction History

Fermata Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$204.13 - $302.4 $172,489 - $255,527	-845 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$255.51 - $362.11 $17,885 - $25,347	-70 Reduced 7.65%	845 $240,000
Q4 2021 Feb 02, 2022	SELL	$351.38 - $448.68 $16,514 - $21,087	-47 Reduced 4.89%	915 $345,000
Q3 2021 Oct 29, 2021	BUY	$372.64 - $458.3 $6,707 - $8,249	18 Added 1.91%	962 $397,000
Q2 2021 Aug 10, 2021	BUY	$294.17 - $371.65 $277,696 - $350,837	944 New	944 $349,000

695

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.45B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Fermata Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fermata Advisors, LLC with notifications on news.